 Benjamin Greenwood
Concepts (272)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Physical Conditioning, Animal | 20 | 2023 | 194 | 5.530 |
Why?
| | Extinction, Psychological | 10 | 2023 | 78 | 3.750 |
Why?
| | Motor Activity | 23 | 2023 | 640 | 3.670 |
Why?
| | Stress, Psychological | 30 | 2023 | 944 | 3.660 |
Why?
| | Fear | 17 | 2023 | 292 | 3.580 |
Why?
| | Helplessness, Learned | 14 | 2016 | 61 | 2.370 |
Why?
| | Corpus Striatum | 9 | 2022 | 126 | 2.320 |
Why?
| | Running | 13 | 2017 | 207 | 2.030 |
Why?
| | Rats | 49 | 2023 | 4958 | 1.750 |
Why?
| | Serotonin | 13 | 2019 | 292 | 1.750 |
Why?
| | Raphe Nuclei | 9 | 2019 | 110 | 1.680 |
Why?
| | Rats, Inbred F344 | 27 | 2019 | 241 | 1.580 |
Why?
| | Memory Consolidation | 2 | 2018 | 11 | 1.210 |
Why?
| | Stress, Physiological | 11 | 2014 | 378 | 1.190 |
Why?
| | Conditioning, Classical | 6 | 2020 | 87 | 1.180 |
Why?
| | Body Temperature Regulation | 2 | 2017 | 72 | 1.120 |
Why?
| | TOR Serine-Threonine Kinases | 3 | 2020 | 358 | 1.090 |
Why?
| | Receptor, Serotonin, 5-HT2C | 5 | 2013 | 14 | 1.070 |
Why?
| | Anxiety | 8 | 2019 | 840 | 1.060 |
Why?
| | Amygdala | 6 | 2017 | 170 | 1.050 |
Why?
| | Animals | 62 | 2023 | 31694 | 1.030 |
Why?
| | Brain | 11 | 2020 | 2371 | 1.000 |
Why?
| | Prefrontal Cortex | 6 | 2017 | 262 | 0.970 |
Why?
| | Reward | 4 | 2018 | 211 | 0.910 |
Why?
| | Conditioning, Operant | 4 | 2011 | 97 | 0.870 |
Why?
| | Dopaminergic Neurons | 3 | 2018 | 43 | 0.840 |
Why?
| | Rats, Long-Evans | 5 | 2022 | 98 | 0.820 |
Why?
| | Implosive Therapy | 2 | 2023 | 35 | 0.780 |
Why?
| | Dopamine | 3 | 2018 | 236 | 0.750 |
Why?
| | Proto-Oncogene Proteins c-fos | 8 | 2019 | 164 | 0.730 |
Why?
| | Behavior, Animal | 9 | 2020 | 458 | 0.710 |
Why?
| | Avoidance Learning | 3 | 2018 | 63 | 0.690 |
Why?
| | Hypothalamus | 2 | 2017 | 147 | 0.680 |
Why?
| | Male | 54 | 2023 | 55554 | 0.650 |
Why?
| | N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2018 | 10 | 0.640 |
Why?
| | Serotonin Agents | 1 | 2018 | 8 | 0.640 |
Why?
| | Physical Exertion | 4 | 2019 | 209 | 0.630 |
Why?
| | Hippocampus | 5 | 2017 | 693 | 0.610 |
Why?
| | Neurons | 7 | 2017 | 1279 | 0.610 |
Why?
| | Electroshock | 12 | 2017 | 134 | 0.600 |
Why?
| | Substantia Nigra | 1 | 2017 | 38 | 0.580 |
Why?
| | Sex Characteristics | 3 | 2019 | 640 | 0.560 |
Why?
| | Ventral Tegmental Area | 1 | 2017 | 45 | 0.550 |
Why?
| | Exercise | 4 | 2023 | 1644 | 0.540 |
Why?
| | Rats, Sprague-Dawley | 14 | 2023 | 2218 | 0.540 |
Why?
| | RNA, Messenger | 12 | 2022 | 2552 | 0.540 |
Why?
| | Hypothermia | 1 | 2016 | 38 | 0.530 |
Why?
| | Neuronal Plasticity | 4 | 2016 | 209 | 0.530 |
Why?
| | Emotions | 3 | 2018 | 472 | 0.530 |
Why?
| | Wakefulness | 1 | 2016 | 128 | 0.510 |
Why?
| | Neural Inhibition | 1 | 2016 | 140 | 0.510 |
Why?
| | Memory | 4 | 2020 | 211 | 0.500 |
Why?
| | Analysis of Variance | 9 | 2017 | 1226 | 0.500 |
Why?
| | Volition | 2 | 2017 | 31 | 0.480 |
Why?
| | Freezing Reaction, Cataleptic | 6 | 2017 | 22 | 0.470 |
Why?
| | Escape Reaction | 3 | 2012 | 58 | 0.460 |
Why?
| | Brain-Derived Neurotrophic Factor | 4 | 2016 | 106 | 0.440 |
Why?
| | Receptors, Dopamine D2 | 4 | 2018 | 86 | 0.400 |
Why?
| | Rats, Wistar | 3 | 2017 | 368 | 0.400 |
Why?
| | Circadian Rhythm | 4 | 2016 | 354 | 0.380 |
Why?
| | Receptors, Adrenergic, alpha-1 | 3 | 2010 | 41 | 0.380 |
Why?
| | Body Weight | 7 | 2020 | 868 | 0.370 |
Why?
| | Neostriatum | 2 | 2022 | 29 | 0.360 |
Why?
| | Limbic System | 1 | 2010 | 43 | 0.360 |
Why?
| | Cognition | 2 | 2017 | 988 | 0.350 |
Why?
| | Association Learning | 1 | 2010 | 60 | 0.330 |
Why?
| | Receptor, Serotonin, 5-HT1A | 3 | 2016 | 39 | 0.330 |
Why?
| | Receptors, Dopamine D1 | 3 | 2018 | 25 | 0.330 |
Why?
| | Locomotion | 2 | 2012 | 80 | 0.330 |
Why?
| | Corticosterone | 6 | 2014 | 211 | 0.310 |
Why?
| | Fluvoxamine | 1 | 2008 | 12 | 0.310 |
Why?
| | Auditory Perception | 3 | 2017 | 102 | 0.300 |
Why?
| | Exercise Therapy | 2 | 2008 | 350 | 0.290 |
Why?
| | Tetrodotoxin | 2 | 2017 | 39 | 0.290 |
Why?
| | Stress Disorders, Post-Traumatic | 3 | 2023 | 757 | 0.280 |
Why?
| | Catecholamines | 3 | 2005 | 94 | 0.280 |
Why?
| | Social Behavior | 4 | 2020 | 267 | 0.270 |
Why?
| | Norepinephrine | 2 | 2017 | 201 | 0.270 |
Why?
| | Depression | 2 | 2012 | 1133 | 0.260 |
Why?
| | Nucleus Accumbens | 2 | 2017 | 124 | 0.250 |
Why?
| | Receptor, Serotonin, 5-HT1B | 1 | 2005 | 5 | 0.250 |
Why?
| | Tyrosine 3-Monooxygenase | 3 | 2016 | 68 | 0.240 |
Why?
| | Acoustic Stimulation | 4 | 2015 | 314 | 0.230 |
Why?
| | Cues | 3 | 2018 | 300 | 0.230 |
Why?
| | Membrane Transport Proteins | 1 | 2005 | 138 | 0.230 |
Why?
| | Ovariectomy | 1 | 2023 | 116 | 0.220 |
Why?
| | Exercise Test | 2 | 2006 | 544 | 0.210 |
Why?
| | Genes, fos | 1 | 2003 | 33 | 0.210 |
Why?
| | Neural Pathways | 3 | 2015 | 261 | 0.210 |
Why?
| | Membrane Glycoproteins | 1 | 2005 | 430 | 0.210 |
Why?
| | HSP72 Heat-Shock Proteins | 3 | 2013 | 26 | 0.200 |
Why?
| | Depressive Disorder | 3 | 2012 | 332 | 0.200 |
Why?
| | In Situ Hybridization | 4 | 2012 | 292 | 0.190 |
Why?
| | Sympathetic Nervous System | 1 | 2003 | 171 | 0.190 |
Why?
| | Adrenal Glands | 3 | 2015 | 66 | 0.190 |
Why?
| | Body Temperature | 3 | 2017 | 208 | 0.190 |
Why?
| | Time Factors | 6 | 2016 | 6112 | 0.190 |
Why?
| | Nerve Tissue Proteins | 1 | 2005 | 529 | 0.190 |
Why?
| | Dentate Gyrus | 3 | 2010 | 30 | 0.190 |
Why?
| | Gene Expression Regulation | 6 | 2010 | 2319 | 0.180 |
Why?
| | Cytokines | 4 | 2016 | 1840 | 0.180 |
Why?
| | Appetite | 1 | 2020 | 52 | 0.170 |
Why?
| | Aminopyridines | 3 | 2009 | 81 | 0.170 |
Why?
| | Sirolimus | 1 | 2020 | 181 | 0.170 |
Why?
| | Serotonergic Neurons | 1 | 2019 | 24 | 0.170 |
Why?
| | Tryptophan Hydroxylase | 1 | 2019 | 52 | 0.160 |
Why?
| | Heart Rate | 3 | 2017 | 709 | 0.160 |
Why?
| | Ketamine | 1 | 2019 | 92 | 0.160 |
Why?
| | Microdialysis | 3 | 2015 | 49 | 0.150 |
Why?
| | Indoles | 3 | 2009 | 304 | 0.150 |
Why?
| | 3,4-Dihydroxyphenylacetic Acid | 1 | 2017 | 17 | 0.150 |
Why?
| | Rats, Transgenic | 1 | 2017 | 15 | 0.150 |
Why?
| | Eating | 1 | 2020 | 344 | 0.150 |
Why?
| | Estrus | 1 | 2017 | 11 | 0.150 |
Why?
| | Citalopram | 1 | 2017 | 27 | 0.140 |
Why?
| | Female | 7 | 2023 | 59466 | 0.140 |
Why?
| | Skin Temperature | 1 | 2016 | 16 | 0.140 |
Why?
| | Cold Temperature | 1 | 2017 | 126 | 0.140 |
Why?
| | Sodium Channel Blockers | 1 | 2016 | 23 | 0.140 |
Why?
| | Exercise Movement Techniques | 1 | 2016 | 4 | 0.140 |
Why?
| | Lactoferrin | 1 | 2016 | 28 | 0.140 |
Why?
| | Psychological Tests | 1 | 2017 | 120 | 0.140 |
Why?
| | Secondary Prevention | 1 | 2018 | 222 | 0.140 |
Why?
| | Prebiotics | 1 | 2016 | 23 | 0.140 |
Why?
| | Energy Metabolism | 2 | 2020 | 731 | 0.130 |
Why?
| | Models, Neurological | 1 | 2018 | 212 | 0.130 |
Why?
| | Fibroblast Growth Factor 2 | 2 | 2006 | 83 | 0.130 |
Why?
| | Sleep, REM | 1 | 2016 | 50 | 0.130 |
Why?
| | Vaccines, Inactivated | 1 | 2016 | 68 | 0.130 |
Why?
| | Neuroglia | 1 | 2017 | 150 | 0.130 |
Why?
| | Bacterial Vaccines | 1 | 2016 | 61 | 0.130 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2016 | 127 | 0.120 |
Why?
| | Random Allocation | 2 | 2014 | 335 | 0.120 |
Why?
| | Recurrence | 1 | 2018 | 935 | 0.120 |
Why?
| | Neuralgia | 1 | 2016 | 122 | 0.120 |
Why?
| | Mycobacterium | 1 | 2016 | 103 | 0.120 |
Why?
| | Interleukin-18 | 2 | 2012 | 219 | 0.120 |
Why?
| | Anxiety Disorders | 2 | 2008 | 303 | 0.120 |
Why?
| | Adrenocorticotropic Hormone | 3 | 2010 | 128 | 0.120 |
Why?
| | Sex Factors | 1 | 2019 | 1715 | 0.110 |
Why?
| | Adipose Tissue, White | 1 | 2013 | 27 | 0.110 |
Why?
| | Colitis | 1 | 2016 | 223 | 0.110 |
Why?
| | Interleukin-1beta | 2 | 2012 | 370 | 0.110 |
Why?
| | Disease Models, Animal | 5 | 2016 | 3531 | 0.110 |
Why?
| | Phosphorylation | 1 | 2017 | 1569 | 0.100 |
Why?
| | Pituitary-Adrenal System | 2 | 2010 | 130 | 0.100 |
Why?
| | Serotonin 5-HT2 Receptor Agonists | 2 | 2008 | 6 | 0.100 |
Why?
| | Hypothalamo-Hypophyseal System | 2 | 2010 | 164 | 0.100 |
Why?
| | Chemokines | 1 | 2012 | 216 | 0.100 |
Why?
| | Locus Coeruleus | 1 | 2011 | 19 | 0.100 |
Why?
| | Inflammasomes | 1 | 2012 | 115 | 0.090 |
Why?
| | Receptors, Opioid, delta | 1 | 2010 | 8 | 0.090 |
Why?
| | Humans | 8 | 2023 | 114623 | 0.090 |
Why?
| | Glucocorticoids | 1 | 2015 | 532 | 0.090 |
Why?
| | Morphine | 1 | 2011 | 121 | 0.090 |
Why?
| | Signal Transduction | 2 | 2020 | 4509 | 0.080 |
Why?
| | Stress Disorders, Traumatic | 1 | 2009 | 23 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2023 | 2094 | 0.080 |
Why?
| | CA1 Region, Hippocampal | 1 | 2009 | 29 | 0.080 |
Why?
| | Diet | 1 | 2016 | 1080 | 0.080 |
Why?
| | Serotonin 5-HT2 Receptor Antagonists | 1 | 2008 | 10 | 0.080 |
Why?
| | Chemokine CCL2 | 3 | 2013 | 105 | 0.080 |
Why?
| | Reaction Time | 1 | 2010 | 376 | 0.080 |
Why?
| | Habituation, Psychophysiologic | 1 | 2008 | 48 | 0.080 |
Why?
| | Nerve Net | 1 | 2010 | 226 | 0.070 |
Why?
| | Reinforcement Schedule | 1 | 2007 | 29 | 0.070 |
Why?
| | Interleukin-10 | 3 | 2013 | 299 | 0.070 |
Why?
| | Receptors, Catecholamine | 1 | 2006 | 4 | 0.070 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2006 | 38 | 0.070 |
Why?
| | Bacteria | 1 | 2012 | 725 | 0.070 |
Why?
| | Fluoxetine | 1 | 2006 | 46 | 0.070 |
Why?
| | Physical Endurance | 1 | 2006 | 232 | 0.060 |
Why?
| | Brain Chemistry | 1 | 2005 | 115 | 0.060 |
Why?
| | Psychomotor Performance | 1 | 2007 | 280 | 0.060 |
Why?
| | Interleukin-6 | 3 | 2013 | 676 | 0.060 |
Why?
| | Escherichia coli Infections | 1 | 2005 | 100 | 0.060 |
Why?
| | Fatigue | 1 | 2006 | 294 | 0.060 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 1 | 2005 | 72 | 0.060 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 1 | 2004 | 32 | 0.060 |
Why?
| | Down-Regulation | 1 | 2006 | 594 | 0.060 |
Why?
| | Spleen | 2 | 2003 | 487 | 0.060 |
Why?
| | Central Nervous System | 1 | 2006 | 235 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2008 | 1842 | 0.060 |
Why?
| | Encephalitis | 1 | 2005 | 127 | 0.060 |
Why?
| | Analgesics, Opioid | 1 | 2011 | 771 | 0.060 |
Why?
| | Immunohistochemistry | 3 | 2019 | 1629 | 0.050 |
Why?
| | Receptors, Serotonin, 5-HT1 | 1 | 2003 | 6 | 0.050 |
Why?
| | CD5 Antigens | 1 | 2003 | 8 | 0.050 |
Why?
| | Receptors, Serotonin | 1 | 2003 | 32 | 0.050 |
Why?
| | CD11 Antigens | 1 | 2003 | 30 | 0.050 |
Why?
| | Stem Cells | 1 | 2006 | 545 | 0.050 |
Why?
| | Immunoglobulin M | 1 | 2003 | 246 | 0.050 |
Why?
| | Interleukin-1 | 1 | 2005 | 966 | 0.050 |
Why?
| | Electric Stimulation | 2 | 2013 | 250 | 0.040 |
Why?
| | Mice | 2 | 2016 | 14860 | 0.040 |
Why?
| | B-Lymphocytes | 1 | 2003 | 766 | 0.040 |
Why?
| | Energy Intake | 1 | 2020 | 427 | 0.040 |
Why?
| | Up-Regulation | 2 | 2012 | 807 | 0.030 |
Why?
| | Activating Transcription Factor 3 | 1 | 2016 | 4 | 0.030 |
Why?
| | Receptors, Purinergic P2X5 | 1 | 2016 | 4 | 0.030 |
Why?
| | Excitatory Amino Acid Transporter 2 | 1 | 2016 | 13 | 0.030 |
Why?
| | p21-Activated Kinases | 1 | 2016 | 14 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2002 | 720 | 0.030 |
Why?
| | Ganglia, Spinal | 1 | 2016 | 41 | 0.030 |
Why?
| | Sciatic Neuropathy | 1 | 2016 | 24 | 0.030 |
Why?
| | Nitrites | 1 | 2016 | 75 | 0.030 |
Why?
| | Gene Expression | 2 | 2014 | 1421 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 2016 | 208 | 0.030 |
Why?
| | Functional Laterality | 1 | 2016 | 198 | 0.030 |
Why?
| | Hyperalgesia | 1 | 2016 | 107 | 0.030 |
Why?
| | Microfilament Proteins | 1 | 2016 | 126 | 0.030 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 260 | 0.030 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2016 | 144 | 0.030 |
Why?
| | Adrenalectomy | 1 | 2015 | 60 | 0.030 |
Why?
| | Calcium-Binding Proteins | 1 | 2016 | 206 | 0.030 |
Why?
| | Photoperiod | 1 | 2015 | 48 | 0.030 |
Why?
| | Enkephalins | 1 | 2014 | 13 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 797 | 0.030 |
Why?
| | Dynorphins | 1 | 2014 | 9 | 0.030 |
Why?
| | Receptor, Adenosine A1 | 1 | 2014 | 11 | 0.030 |
Why?
| | Receptor, Adenosine A2A | 1 | 2014 | 20 | 0.030 |
Why?
| | Leukocytes, Mononuclear | 1 | 2016 | 493 | 0.030 |
Why?
| | Immunization | 1 | 2016 | 397 | 0.030 |
Why?
| | Cell Count | 2 | 2006 | 303 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2016 | 339 | 0.030 |
Why?
| | Telemetry | 1 | 2013 | 36 | 0.030 |
Why?
| | Caspase Inhibitors | 1 | 2012 | 78 | 0.030 |
Why?
| | Area Under Curve | 1 | 2013 | 274 | 0.030 |
Why?
| | Caspase 1 | 1 | 2012 | 140 | 0.020 |
Why?
| | Adaptation, Physiological | 2 | 2006 | 483 | 0.020 |
Why?
| | Uric Acid | 1 | 2012 | 148 | 0.020 |
Why?
| | 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2009 | 9 | 0.020 |
Why?
| | Radioimmunoassay | 1 | 2010 | 162 | 0.020 |
Why?
| | Restraint, Physical | 1 | 2010 | 67 | 0.020 |
Why?
| | Serotonin Receptor Agonists | 1 | 2009 | 27 | 0.020 |
Why?
| | Serotonin Antagonists | 1 | 2009 | 30 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2012 | 821 | 0.020 |
Why?
| | Noise | 1 | 2010 | 68 | 0.020 |
Why?
| | Injections, Intraperitoneal | 1 | 2008 | 99 | 0.020 |
Why?
| | Pyrazines | 1 | 2008 | 71 | 0.020 |
Why?
| | Organ Size | 1 | 2008 | 434 | 0.020 |
Why?
| | Thymus Gland | 1 | 2008 | 296 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2009 | 778 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2016 | 4689 | 0.020 |
Why?
| | Biogenic Monoamines | 1 | 2006 | 13 | 0.020 |
Why?
| | Gyrus Cinguli | 1 | 2006 | 70 | 0.020 |
Why?
| | Piperazines | 1 | 2008 | 309 | 0.020 |
Why?
| | Tail | 1 | 2006 | 29 | 0.020 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2006 | 30 | 0.020 |
Why?
| | Bromodeoxyuridine | 1 | 2006 | 72 | 0.020 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2006 | 79 | 0.020 |
Why?
| | Labetalol | 1 | 2005 | 5 | 0.020 |
Why?
| | Prazosin | 1 | 2005 | 24 | 0.020 |
Why?
| | Adrenergic alpha-Antagonists | 1 | 2005 | 29 | 0.020 |
Why?
| | Propranolol | 1 | 2005 | 49 | 0.020 |
Why?
| | Behavior | 1 | 2006 | 92 | 0.020 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2005 | 287 | 0.010 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2004 | 144 | 0.010 |
Why?
| | Peritoneum | 1 | 2003 | 36 | 0.010 |
Why?
| | Lymphocyte Count | 1 | 2003 | 133 | 0.010 |
Why?
| | Cell Survival | 1 | 2006 | 1020 | 0.010 |
Why?
| | Neuropsychological Tests | 1 | 2006 | 927 | 0.010 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2002 | 59 | 0.010 |
Why?
| | Adaptation, Psychological | 1 | 2006 | 547 | 0.010 |
Why?
| | Leukocyte Count | 1 | 2002 | 293 | 0.010 |
Why?
| | Lymph Nodes | 1 | 2003 | 419 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2003 | 1083 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2006 | 2186 | 0.010 |
Why?
| | Escherichia coli | 1 | 2002 | 720 | 0.010 |
Why?
| | Skin | 1 | 2002 | 655 | 0.010 |
Why?
| | Neutrophils | 1 | 2002 | 1176 | 0.010 |
Why?
| | Inflammation | 1 | 2002 | 2477 | 0.010 |
Why?
|
|
Greenwood's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|